The Japanese Journal of Pharmacology · 2002 · 21 citations · 31 references
Life SciencesNeurobiologyNeuroscienceApoptosisCellular NeurobiologyMolecular NeuroscienceApoptosis In NeurodegenerationCellular Responses To HypoxiaHypoxic-ischemic Brain InjuryNeurodegenerative DiseasesNeuronal Cell DeathNeuroprotectionAmyloid ToxicityAmyloid-associated NeurotoxicityAmyloid-beta Induced ApoptosisAmyloid-beta-induced NeurotoxicityCell Death In NeurodegenerationNeural ApoptosisNmda Receptor AntagonistsNmda Receptors
We investigated the effect of hypoxia on beta-amyloid (Abeta)-induced apoptosis in rat cultured hippocampal neurons. Abeta (25 microM for 48 h) decreased the number of neuronal cells and increased the number of TUNEL-positive cells. Hypoxia (6 h) also decreased the number of neuronal cells, but did not increase the number of TUNEL-positive cells. Moreover, combined treatment with both Abeta and hypoxia (Abeta/hypoxia) significantly enhanced the decrease in the number of neuronal cells and the increase in the number of TUNEL-positive cells. Z-Asp-CH(2)-DCB, an inhibitor of interleukin-1beta-converting enzyme (ICE), or 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), a non-N-methyl-D-aspartate (non-NMDA) receptor antagonist, decreased the number of TUNEL-positive cells with Abeta/hypoxia. These findings suggest that ischemia or hypoxia is an important factor that facilitates the symptoms of Alzheimer's disease and that non-NMDA receptors are involved in the induction of apoptosis in patients suffering from both cerebrovascular disease and Alzheimer's disease.
31
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
David A. Snowdon · JAMA · 1997 · 2K citations
Medicine, Neurology, Neuroscience +14
15-year longitudinal study of blood pressure and dementia
Ingmar Skoog, Lennart Nilsson, G. Persson et al. · The Lancet · 1996 · 1.7K citations